chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Cardiac stress test, Chest pain, Computerised tomogram coronary artery abnormal, Disease recurrence
Clinical narrative: I experienced intense pain in my back that radiated to my chest and left arm; attributed the pain to supposed pinched nerve; sore arm; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 12Feb2021 12:00 (Batch/Lot Number: EM9809) as single dose for COVID-19 immunisation. Medical history included partially blocked cardiac arteries and heart palpitation (in Nov2020, patient consulted a cardiologist for heart palpitations. He recommended that patient receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, he felt that patient's condition was stable and recommended against catheterization). Known allergies included Sulfa and ciprofloxacin (CIPRO). Concomitant medications included vitamin D at 1000 iU, taken for an unspecified indication, start and stop date were not reported. Patient received first BNT162B2 shot on 12Feb2021. The only initial side effect was a sore arm in Feb2021 that lasted for a day. However, about two weeks after the first shot (Feb2021), patient went for a two-mile walk. Soon after patient started, he experienced intense pain in back that radiated to chest and left arm. Patient returned home and the pain subsided quickly. Given his history, patient attributed the pain to his supposed pinched nerve. He tried walking on a couple of successive days, with the same result. Patient received his second vaccination on 05Mar2021 at 12:00 pm (lot number: EN6203) in left arm. Patient began to experience intense pain in back that radiated to chest and left arm about 24 hours later (06Mar2021 at 15:00).The event intense pain in back that radiated to chest and left arm resulted in: Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). Patient was hospitalized for 4 days and received treatment included catherization, insertion of stent. Nasal Swab PCR on 06Mar2021 was negative. Outcome of intense pain in my back that radiated to my chest and left arm and attributed the pain to supposed pinched nerve was resolving. Outcome of sore arm was resolved.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021426808 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, SARS-CoV-2 test
Clinical narrative: I experienced intense pain in my back that radiated to my chest and left arm; attributed the pain to supposed pinched nerve; sore arm; This is a spontaneous report from a contactable consumer (patient). A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 12Feb2021 12:00 (Batch/Lot Number: EM9809) as single dose for COVID-19 immunisation. Medical history included partially blocked cardiac arteries and heart palpitation (in Nov2020, patient consulted a cardiologist for heart palpitations. He recommended that patient receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, he felt that patient's condition was stable and recommended against catheterization). Known allergies included Sulfa and ciprofloxacin (CIPRO). Concomitant medications included vitamin D at 1000 iU, taken for an unspecified indication, start and stop date were not reported. Patient received first BNT162B2 shot on 12Feb2021. The only initial side effect was a sore arm in Feb2021 that lasted for a day. However, about two weeks after the first shot (Feb2021), patient went for a two-mile walk. Soon after patient started, he experienced intense pain in back that radiated to chest and left arm. Patient returned home and the pain subsided quickly. Given his history, patient attributed the pain to his supposed pinched nerve. He tried walking on a couple of successive days, with the same result. Patient received his second vaccination on 05Mar2021 at 12:00 pm (lot number: EN6203) in left arm. Patient began to experience intense pain in back that radiated to chest and left arm about 24 hours later (06Mar2021 at 15:00).The event intense pain in back that radiated to chest and left arm resulted in: Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). Patient was hospitalized for 4 days and received treatment included catherization, insertion of stent. Nasal Swab PCR on 06Mar2021 was negative. Outcome of intense pain in my back that radiated to my chest and left arm and attributed the pain to supposed pinched nerve was resolving. Outcome of sore arm was resolved.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021426808 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Cardiac stress test normal, Catheterisation cardiac, Chest X-ray, Chest pain
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Computerised tomogram, Echocardiogram normal, Electrocardiogram, Fatigue, Full blood count
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myocardial infarction, Nerve compression, Pain, Pain in extremity, SARS-CoV-2 test negative
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Blood calcium, Cardiac stress test, Echocardiogram, Nerve compression
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, SARS-CoV-2 test
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Back pain, Cardiac stress test, Chest pain, Computerised tomogram coronary artery abnormal, Disease recurrence
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Echocardiogram, SARS-CoV-2 test
Clinical narrative: intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; intense pain in his back that radiated to his chest and left arm; This is a spontaneous report from a contactable consumer (patient) reported for himself that a 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in Arm Left on 05Mar2021 12:00 as single dose for COVID-19 immunisation. Medical history included heart palpitations, partially blocked cardiac arteries. Patient was allergic to Sulfa and ciprofloxacin hydrochloride (CIPRO). In Nov2020, patient consulted a cardiologist for heart palpitations. The cardiologist recommended patient to receive a calcium score test. Since this showed moderate risk in two arteries, he referred patient for an echocardiogram and a nuclear stress test, both of which were normal. Based on these results, cardiologist felt that patient's condition was stable and recommended against catherization. Concomitant medication included colecalciferol (VITAMIN D 1000 IU). No COVID prior vaccination. No other vaccine in four weeks. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EM9809) administered in Left arm on 12Feb2021 12:00 PM at the age of 70 years for COVID-19 immunisation and experienced sore arm, intense pain in his back that radiated to chest and left arm, patient attributed the pain to his supposed pinched nerve. Patient received his second vaccination on 05Mar2021. He began to experience intense pain in his back that radiated to his chest and left arm about 24 hours later on 06Mar2021 03:00 PM. The adverse events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness. Patient admitted to hospital for 4 days and received treatment: Catherization, insertion of stent. Patient had COVID-19 PCR test post vaccination via nasal swab on 06Mar2021 and revealed negative result. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423183 same patient and reporter, different dose and event
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: sore throat, headaches; sore throat, headaches; 2 weeks after 1st shot tested positive for COVID; 2 weeks after 1st shot tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 27Jan2021 15:30 (lot number: EN5318) as single dose for COVID-19 immunization. Medical history included atrial fibrillation from 1979 and ongoing, heart ablation, high BP, liver disorder, and thyroid disorder. Concomitant medications included rivaroxaban (XARELTO) taken for atrial fibrillation from an unspecified start date and ongoing; losartan taken for high BP from an unspecified start date and ongoing; ursodiol taken for liver disorder from an unspecified start date and ongoing; levothyroxine taken for thyroid disorder from an unspecified start date and ongoing; metoprolol taken for an unspecified indication from an unspecified start date and ongoing. 2 weeks after 1st shot (Feb2021), the patient tested positive for COVID. The patient did not know how he caught the virus (no travel, wearing mask and kept social distancing). The patient had "no temperature or problem breathing". On an unspecified date, the patient had sore throat, and headaches. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Feb2021. Outcome of the events was unknown.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Ageusia, Anosmia, Body temperature, Cough, Fatigue
Clinical narrative: sore throat, headaches; sore throat, headaches; 2 weeks after 1st shot tested positive for COVID; 2 weeks after 1st shot tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 27Jan2021 15:30 (lot number: EN5318) as single dose for COVID-19 immunization. Medical history included atrial fibrillation from 1979 and ongoing, heart ablation, high BP, liver disorder, and thyroid disorder. Concomitant medications included rivaroxaban (XARELTO) taken for atrial fibrillation from an unspecified start date and ongoing; losartan taken for high BP from an unspecified start date and ongoing; ursodiol taken for liver disorder from an unspecified start date and ongoing; levothyroxine taken for thyroid disorder from an unspecified start date and ongoing; metoprolol taken for an unspecified indication from an unspecified start date and ongoing. 2 weeks after 1st shot (Feb2021), the patient tested positive for COVID. The patient did not know how he caught the virus (no travel, wearing mask and kept social distancing). The patient had "no temperature or problem breathing". On an unspecified date, the patient had sore throat, and headaches. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Feb2021. Outcome of the events was unknown.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Oropharyngeal pain, Oxygen saturation, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: sore throat, headaches; sore throat, headaches; 2 weeks after 1st shot tested positive for COVID; 2 weeks after 1st shot tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 27Jan2021 15:30 (lot number: EN5318) as single dose for COVID-19 immunization. Medical history included atrial fibrillation from 1979 and ongoing, heart ablation, high BP, liver disorder, and thyroid disorder. Concomitant medications included rivaroxaban (XARELTO) taken for atrial fibrillation from an unspecified start date and ongoing; losartan taken for high BP from an unspecified start date and ongoing; ursodiol taken for liver disorder from an unspecified start date and ongoing; levothyroxine taken for thyroid disorder from an unspecified start date and ongoing; metoprolol taken for an unspecified indication from an unspecified start date and ongoing. 2 weeks after 1st shot (Feb2021), the patient tested positive for COVID. The patient did not know how he caught the virus (no travel, wearing mask and kept social distancing). The patient had "no temperature or problem breathing". On an unspecified date, the patient had sore throat, and headaches. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Feb2021. Outcome of the events was unknown.
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, Headache, Oropharyngeal pain, SARS-CoV-2 test
Clinical narrative: sore throat, headaches; sore throat, headaches; 2 weeks after 1st shot tested positive for COVID; 2 weeks after 1st shot tested positive for COVID; This is a spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 27Jan2021 15:30 (lot number: EN5318) as single dose for COVID-19 immunization. Medical history included atrial fibrillation from 1979 and ongoing, heart ablation, high BP, liver disorder, and thyroid disorder. Concomitant medications included rivaroxaban (XARELTO) taken for atrial fibrillation from an unspecified start date and ongoing; losartan taken for high BP from an unspecified start date and ongoing; ursodiol taken for liver disorder from an unspecified start date and ongoing; levothyroxine taken for thyroid disorder from an unspecified start date and ongoing; metoprolol taken for an unspecified indication from an unspecified start date and ongoing. 2 weeks after 1st shot (Feb2021), the patient tested positive for COVID. The patient did not know how he caught the virus (no travel, wearing mask and kept social distancing). The patient had "no temperature or problem breathing". On an unspecified date, the patient had sore throat, and headaches. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on Feb2021. Outcome of the events was unknown.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing tho; It is extremely irritating; Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing tho; This is a spontaneous report from a contactable consumer (patient). This 61- year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: ER8733), via an unspecified route of administration, on 01Mar2021 at 12:00 AM (at the age of 61-years-old) as a single dose for COVID-19 vaccination. The facility where COVID-19 vaccine was administered was reported as "other" and anatomically located on the left arm.  Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection, Lot number EL9265,) dose 1 on 08Feb2021, for covid-19 immunization. No allergies to medications, food, or other products. The medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, she experienced Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing thou is still present 24/7.  It is extremely irritating and there is nothing i can do to make it better. Treatment was  not received for the adverse event. The clinical outcome of the events was not recovered. On 05Apr2021, the patient was tested for COVID-19 via Nasal Swab since having the vaccine, with a negative result.  No follow-up attempts are possible. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Headache, Irritability, Tinnitus
Clinical narrative: Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing tho; It is extremely irritating; Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing tho; This is a spontaneous report from a contactable consumer (patient). This 61- year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Lot number: ER8733), via an unspecified route of administration, on 01Mar2021 at 12:00 AM (at the age of 61-years-old) as a single dose for COVID-19 vaccination. The facility where COVID-19 vaccine was administered was reported as "other" and anatomically located on the left arm.  Historical vaccine included: bnt162b2 (COMIRNATY, Solution for injection, Lot number EL9265,) dose 1 on 08Feb2021, for covid-19 immunization. No allergies to medications, food, or other products. The medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, she experienced Headaches started 2nd day of 2nd vaccine. About day 8, I began having ear ringing along with headaches. It has been 36 days now and the headaches are still there but not as severe. The ear ringing thou is still present 24/7.  It is extremely irritating and there is nothing i can do to make it better. Treatment was  not received for the adverse event. The clinical outcome of the events was not recovered. On 05Apr2021, the patient was tested for COVID-19 via Nasal Swab since having the vaccine, with a negative result.  No follow-up attempts are possible. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction
Clinical narrative: Anaphylactic reaction-throat and tongue swelling; This is a spontaneous report received from a contactable consumer (patient). A 28-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 13:45 (at the age of 28-year-old) as a single dose for COVID-19 immunization in Workplace Clinic. Medical history included ulcerative colitis, hyperthyroidism, hypertension and known allergies: Cephalexen and NSAIDS. The patient did not receive other vaccine in four weeks and received other medications (unspecified) in two weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 14:00, the patient experienced anaphylactic reaction - throat and tongue swelling, which resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received Epi pen (administered 15 minutes after injection of vaccine), benadryl, ER trip, fluids and headache medication as a treatment for the event. The patient recovered with lasting effects. The outcome of the event was recovered with sequel.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Confusional state, Headache, Pharyngeal swelling, Swollen tongue
Clinical narrative: Anaphylactic reaction-throat and tongue swelling; This is a spontaneous report received from a contactable consumer (patient). A 28-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration in the left arm on 24Mar2021 at 13:45 (at the age of 28-year-old) as a single dose for COVID-19 immunization in Workplace Clinic. Medical history included ulcerative colitis, hyperthyroidism, hypertension and known allergies: Cephalexen and NSAIDS. The patient did not receive other vaccine in four weeks and received other medications (unspecified) in two weeks. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 14:00, the patient experienced anaphylactic reaction - throat and tongue swelling, which resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient received Epi pen (administered 15 minutes after injection of vaccine), benadryl, ER trip, fluids and headache medication as a treatment for the event. The patient recovered with lasting effects. The outcome of the event was recovered with sequel.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Eye pruritus, Musculoskeletal discomfort, Oral pruritus, Thrombophlebitis superficial
Clinical narrative: Superficial thrombophlebitis; Breathing difficulties; Itching around mouth, eyes, and joints; Itching around mouth, eyes, and joints; Itching around mouth, eyes, and joints; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 23Mar2021 14:30 (Batch/Lot Number: en6201) at the age of 48 years old, as single dose for covid-19 immunisation. Medical history included asthma, nonalcoholic fatty liver disease (NAFLD), latex allergy, and shellfish allergy; all from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior to vaccination. Concomitant medication included fluticasone propionate (FLOVENT) taken for an unspecified indication, start and stop date were not reported. The patient previously took loratadine (LORTAB) and experienced allergies. On 23Mar2021 14:30, the patient experienced superficial thrombophlebitis, breathing difficulties and itching around mouth, eyes, and joints. Patient was administered with cetirizine HCl 10mg antihistamine at onset of symptoms and 2 puffs Albuterol Sulfate HFA Inhalation Aerosol 90mcg per actuation approximately 90 minutes after onset to control symptoms until they fully subsided. The patient recovered from all the events on unspecified date. The patient has not been tested for COVID post vaccination. No other vaccines received 4 weeks prior to COVID vaccination.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Eye pruritus, Oral pruritus, Pruritus, Thrombophlebitis superficial
Clinical narrative: Superficial thrombophlebitis; Breathing difficulties; Itching around mouth, eyes, and joints; Itching around mouth, eyes, and joints; Itching around mouth, eyes, and joints; This is a spontaneous report from a contactable consumer (patient). A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Right on 23Mar2021 14:30 (Batch/Lot Number: en6201) at the age of 48 years old, as single dose for covid-19 immunisation. Medical history included asthma, nonalcoholic fatty liver disease (NAFLD), latex allergy, and shellfish allergy; all from an unknown date and unknown if ongoing. The patient was not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior to vaccination. Concomitant medication included fluticasone propionate (FLOVENT) taken for an unspecified indication, start and stop date were not reported. The patient previously took loratadine (LORTAB) and experienced allergies. On 23Mar2021 14:30, the patient experienced superficial thrombophlebitis, breathing difficulties and itching around mouth, eyes, and joints. Patient was administered with cetirizine HCl 10mg antihistamine at onset of symptoms and 2 puffs Albuterol Sulfate HFA Inhalation Aerosol 90mcg per actuation approximately 90 minutes after onset to control symptoms until they fully subsided. The patient recovered from all the events on unspecified date. The patient has not been tested for COVID post vaccination. No other vaccines received 4 weeks prior to COVID vaccination.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Feeling cold, Head discomfort, Jaw disorder, Oral discomfort
Clinical narrative: her right foot keeps falling asleep; feels like she was vibrating all over; burning of head from neck up, felt like sunburn/ocasional burning or icing sensations throughout entire body; back of head felt like ice/ocasional burning or icing sensations throughout entire body/feels like ice was running through veins; tingling in head/paresthesia; jaw hurt; This is a spontaneous report from a contactable consumer reported for herself that a 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: er8727) at the age of 50-years, via an unspecified route of administration in left arm on 24Mar2021 07:30 AM at single dose for COVID-19 immunization. Medical history included allergies to dust and mold. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. No other medications the patient received within 2 weeks of vaccination. Patient reported that on 24Mar2021 10:00 AM (day 1), back of head felt like ice, tingling in head, jaw hurt; on 25Mar2021 (day 2), burning of head from neck up, felt like sunburn, back of head burned along with palms; day 3 and 4 - seemed better; day 5-8 - feels like ice was running through veins, feels like she was vibrating all over, ocasional burning or icing sensations throughout entire body. Patient also reported that received 1st dose of vaccine on 24 Mar2021. 15 days later she had paresthesia and her head was burning on the back. Also, the day her right foot keeps falling asleep. She would like to participate in any studies of side effects from this vaccine. She was concerned about receiving the second dose. No treatment received for the adverse events. Outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia
Clinical narrative: her right foot keeps falling asleep; feels like she was vibrating all over; burning of head from neck up, felt like sunburn/ocasional burning or icing sensations throughout entire body; back of head felt like ice/ocasional burning or icing sensations throughout entire body/feels like ice was running through veins; tingling in head/paresthesia; jaw hurt; This is a spontaneous report from a contactable consumer reported for herself that a 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: er8727) at the age of 50-years, via an unspecified route of administration in left arm on 24Mar2021 07:30 AM at single dose for COVID-19 immunization. Medical history included allergies to dust and mold. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. No other medications the patient received within 2 weeks of vaccination. Patient reported that on 24Mar2021 10:00 AM (day 1), back of head felt like ice, tingling in head, jaw hurt; on 25Mar2021 (day 2), burning of head from neck up, felt like sunburn, back of head burned along with palms; day 3 and 4 - seemed better; day 5-8 - feels like ice was running through veins, feels like she was vibrating all over, ocasional burning or icing sensations throughout entire body. Patient also reported that received 1st dose of vaccine on 24 Mar2021. 15 days later she had paresthesia and her head was burning on the back. Also, the day her right foot keeps falling asleep. She would like to participate in any studies of side effects from this vaccine. She was concerned about receiving the second dose. No treatment received for the adverse events. Outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Chills, Feeling cold, Hypoaesthesia, Pain in jaw
Clinical narrative: her right foot keeps falling asleep; feels like she was vibrating all over; burning of head from neck up, felt like sunburn/ocasional burning or icing sensations throughout entire body; back of head felt like ice/ocasional burning or icing sensations throughout entire body/feels like ice was running through veins; tingling in head/paresthesia; jaw hurt; This is a spontaneous report from a contactable consumer reported for herself that a 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: er8727) at the age of 50-years, via an unspecified route of administration in left arm on 24Mar2021 07:30 AM at single dose for COVID-19 immunization. Medical history included allergies to dust and mold. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. No other medications the patient received within 2 weeks of vaccination. Patient reported that on 24Mar2021 10:00 AM (day 1), back of head felt like ice, tingling in head, jaw hurt; on 25Mar2021 (day 2), burning of head from neck up, felt like sunburn, back of head burned along with palms; day 3 and 4 - seemed better; day 5-8 - feels like ice was running through veins, feels like she was vibrating all over, ocasional burning or icing sensations throughout entire body. Patient also reported that received 1st dose of vaccine on 24 Mar2021. 15 days later she had paresthesia and her head was burning on the back. Also, the day her right foot keeps falling asleep. She would like to participate in any studies of side effects from this vaccine. She was concerned about receiving the second dose. No treatment received for the adverse events. Outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Medical observation, Paraesthesia, Pharyngeal hypoaesthesia, Skin tightness
Clinical narrative: Tightness in forehead 3 minutes after getting the shot. 5 minutes after getting the shot, tingling in my face and lips occurred, my throat closed and my heart rate shot up to 170 bpm while sitting. Difficult breathing for 15 minutes after getting the shot.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vital signs measurement
Clinical narrative: Tightness in forehead 3 minutes after getting the shot. 5 minutes after getting the shot, tingling in my face and lips occurred, my throat closed and my heart rate shot up to 170 bpm while sitting. Difficult breathing for 15 minutes after getting the shot.
Age: 22.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Heart rate increased, Paraesthesia, Paraesthesia oral, Skin tightness
Clinical narrative: Tightness in forehead 3 minutes after getting the shot. 5 minutes after getting the shot, tingling in my face and lips occurred, my throat closed and my heart rate shot up to 170 bpm while sitting. Difficult breathing for 15 minutes after getting the shot.